Skeletal muscle triglyceride levels are inversely related to insulin action

Diabetes
D A PanL H Storlien

Abstract

In animal studies, increased amounts of triglyceride associated with skeletal muscle (mTG) correlate with reduced skeletal muscle and whole body insulin action. The aim of this study was to test this relationship in humans. Subjects were 38 nondiabetic male Pima Indians (mean age 28 +/- 1 years). Insulin sensitivity at physiological (M) and supraphysiological (MZ) insulin levels was assessed by the euglycemic clamp. Lipid and carbohydrate oxidation were determined by indirect calorimetry before and during insulin administration. mTG was determined in vastus lateralis muscles obtained by percutaneous biopsy. Percentage of body fat (mean 29 +/- 1%, range 14-44%) was measured by underwater weighing. In simple regressions, negative relationships were found between mTG (mean 5.4 +/- 0.3 micromol/g, range 1.3-1.9 micromol/g) and log10M (r = -0.53, P < or = 0.001), MZ (r = -0.44, P = 0.006), and nonoxidative glucose disposal (r = -0.48 and -0.47 at physiological and supraphysiological insulin levels, respectively, both P = 0.005) but not glucose or lipid oxidation. mTG was not related to any measure of adiposity. In multiple regressions, measures of insulin resistance (log10M, MZ, log10[fasting insulin]) were significantly related to ...Continue Reading

Citations

Feb 17, 2001·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·K BrechtelF Schick
Mar 29, 2002·Diabetes/metabolism Research and Reviews·Shaoming Song
Jul 12, 2002·Diabetes/metabolism Research and Reviews·Eleazar ShafrirNeil B Ruderman
Sep 24, 2004·Diabetes/metabolism Research and Reviews·Itamar RazEleazar Shafrir
Jan 23, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Vance B Matthews, Mark A Febbraio
Jan 16, 2007·Skeletal Radiology·Martin Torriani
Aug 7, 2008·Skeletal Radiology·Michele GaetaSilvio Mazziotti
Jul 21, 2005·European Journal of Applied Physiology·Eric D B GouletIsabelle J Dionne
Dec 21, 2000·Current Atherosclerosis Reports·J C Lovejoy
Mar 20, 2003·Current Diabetes Reports·Steven R Smith, Eric Ravussin
Jul 16, 2008·Current Diabetes Reports·Angelika Lettner, Michael Roden
Jan 29, 2013·Current Diabetes Reports·Khaled Imad Khalaf, Heinrich Taegtmeyer
Mar 23, 2004·Biochemical and Biophysical Research Communications·Morten DonsmarkHenrik Galbo
Jul 4, 2012·Molecular and Cellular Endocrinology·Yonit MarcusNaftali Stern
Jul 25, 2003·Experimental Cell Research·Dorte HolstPaul A Grimaldi
Aug 5, 2003·Metabolism: Clinical and Experimental·Martin MuurlingPeter J Voshol
Dec 12, 2003·Metabolism: Clinical and Experimental·Chul-Hee KimKi-Up Lee
Apr 7, 2000·Molecular Aspects of Medicine·J MercierR Ventura
Sep 24, 2002·International Journal of Cardiology·Altan OnatGülay Hergenç
Oct 24, 2002·Advanced Drug Delivery Reviews·James M Lenhard, William K Gottschalk
Jul 20, 1999·Molecular and Cellular Endocrinology·J ProiettoS Clark
Dec 1, 2001·Endocrinology and Metabolism Clinics of North America·G Boden
Dec 31, 2002·Journal of Diabetes and Its Complications·Nicola Abate, Manisha Chandalia
Sep 16, 2000·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·L Groop

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.